| Authors: |
Geoffre N; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neurosciences & Cognition, Lille, France.; Department of Toxicology and Genopathies, Lille University Hospital, Lille, France., Ollivier T; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neurosciences & Cognition, Lille, France.; Neurology and Movement Disorders Department, Expert Center for Parkinson's Disease, Lille University Hospital, Lille, France., Baille G; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neurosciences & Cognition, Lille, France.; Neurology and Movement Disorders Department, Expert Center for Parkinson's Disease, Lille University Hospital, Lille, France.; Neurology Department, Foundation Rothschild, Paris, France., Defebvre L; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neurosciences & Cognition, Lille, France.; Neurology and Movement Disorders Department, Expert Center for Parkinson's Disease, Lille University Hospital, Lille, France., Huin V; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neurosciences & Cognition, Lille, France.; Department of Toxicology and Genopathies, Lille University Hospital, Lille, France., Mutez E; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neurosciences & Cognition, Lille, France.; Neurology and Movement Disorders Department, Expert Center for Parkinson's Disease, Lille University Hospital, Lille, France. |